Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
We provide 1 form of Brigatinib
Brigatinib
1197953-54-0
|
583.259
|
2.024
Brigatinib is an anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer.
AP26113 | alunbrig | brigatinib
Brigatinib is an anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer.
AP26113 | alunbrig | brigatinib
$55/5 mg
(EBC)
1
We provide 0 compound for Brigatinib
Powered by Bioz